Patents by Inventor Rajesh Thangapazham

Rajesh Thangapazham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Skin substitutes and methods for hair follicle neogenesis
    Patent number: 10478526
    Abstract: This invention provides compositions in the form of skin substitutes comprising epithelial cells and mesenchymal cells, wherein the mesenchymal cells are not isolated from the occipital or nape region of the scalp, as well as methods for using the same.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: November 19, 2019
    Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Rajesh Thangapazham, Thomas N. Darling, Shaowei Li
  • SKIN SUBSTITUTES AND METHODS FOR HAIR FOLLICLE NEOGENESIS
    Publication number: 20160184481
    Abstract: This invention provides compositions in the form of skin substitutes comprising epithelial cells and mesenchymal cells, wherein the mesenchymal cells are not isolated from the occipital or nape region of the scalp, as well as methods for using the same.
    Type: Application
    Filed: May 1, 2014
    Publication date: June 30, 2016
    Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: Rajesh Thangapazham, Thomas N. Darling, Shaowei Li
  • HAIR FOLLICLE NEOGENESIS
    Publication number: 20130209427
    Abstract: This invention provides a skin substitute comprising epithelial cells and modified mesenchymal cells, wherein the modified mesenchymal cells have decreased TSC1/TSC2 function, increased mTORCI function, and/or decreased mTORC2 function compared to wild type mesenchymal cells, and methods for using the same. This invention also provides a method for transplanting cells capable of inducing hair follicles, comprising subdermally or intradermally delivering to a patient modified mesenchymal cells, wherein the modified mesenchymal cells have decreased TSC1/TSC2 function, increased mTORCI function, and/or decreased mTORC2 function compared to wild type mesenchymal cells.
    Type: Application
    Filed: June 17, 2011
    Publication date: August 15, 2013
    Inventors: Rajesh Thangapazham, Thomas N. Darling, Shaowei Li